EMJ Podcast: Insights For Healthcare Professionals

This content was funded by an educational grant from Pfizer. The views and opinions expressed are those of the speakers and not necessarily of Pfizer.

This week, Jonathan discusses the ancient spiritual practices of yoga and meditation, outlining historical and scientific evidence of how these methods can improve physical and mental wellbeing and help us to ‘stretch the stress away.’ Jonathan details the global interest in yoga, from its roots in Northern India over 5,000 years ago, right through to the spread of its popularity in the 20th Century, and how performing ‘asanas’ and ‘pranayamas’ may provide strong clinical benefits for patients with a range of conditions, on and off the mat.

The music used in this episode is taken from https://www.FesliyanStudios.com 

Dr. Subarna Chakravorty and Dr. Rachel Kesse-Adu discuss their highlights from ASH surrounding sickle cell disease.

Focussing on the presentations, posters and abstracts around the current advances and future possibilities of SCD. Novel approaches for treatment and new therapies.

This podcast was funded by Novartis, the views and opinions expressed are those of the speakers and do not necessarily represent the position of Novartis. All content was generated independently of Novartis.

This podcast is only for use by healthcare professionals. This educational podcast has been fully sponsored by UCB and the content does not necessarily reflect the views of UCB.* Prof. Ryan has received honoraria for serving on advisory boards, as a speaker, or as a consultant from AbbVie, Allergan, Aqua, Dermira, Dr Reddy’s, Janssen, Leo, Lilly, Medimetriks, Novartis, Regeneron-Sanofi, UCB, and Xenoport. For further information on how UCB processes personal data click HERE https://www.ucb.com/Privacy-policy-for-Healthcare-Professionals

This week, Jonathan hosts Chiara De Biase, Director of Support and Influencing, Prostate Cancer UK, and Amy Rylance, Head of Improving Care, Prostate Cancer UK. They discuss the implications of the coronavirus pandemic on prostate cancer in the UK, as well as current modes of raising awareness, and emerging treatment options in the form of novel hormonal therapies.  

Access the Prostate Cancer UK website here: www.prostatecanceruk.org

Use this link to complete the risk checker discussed in this episode: https://prostatecanceruk.org/risk-checker  

Oral contraception is a great asset in family planning that leads to female empowerment. In this podcast three leading experts from the field of gynecology and hemostasis Kristina Gemzell Danielsson, Diana Mansour and Jonathan Douxfils discuss the brief history and development of combined oral contraceptives and talk about access to contraception during the COVID-19 pandemic. They will also have a discussion about the present situation of VTE risk and combined hormonal contraception and will present data on effect on hemostasis parameters of the estetrol 14.2 mg and drospirenone 3 mg combination. (14.2 mg estetrol as 15 mg estetrol monohydrate)

Disclaimer: The publication of this podcast was funded by Gedeon Richter. The discussion represents the opinion of the speakers and was not influenced by Gedeon Richter. The information contained in this podcast is solely for healthcare professionals and is not for an audience without the relevant education. It is not intended as, and shall not be understood or construed as, medical or health advice.

In this podcast, hosted by Julie Ann Lough, experts in oesophageal cancer come together to discuss current treatments, and offer valuable insights into the future of the field. This follows from the European Society of Medical Oncology (ESMO) satellite session titled ‘Navigating the Current Treatment Landscape in Oesophageal Cancer with an Eye Toward the Future’, which took place in September 2021.

Lough is joined by three specialist oncologists: Elizabeth Smyth, a Consultant in Gastrointestinal Oncology, Addenbrooke’s Hospital, Cambridge, UK; Jean-Phillippe Metges, an Oncologist at the University Hospital of Brest, France; and Lucjan Wyrwicz, a Professor and Head of the Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Cancer Research Institute, Warsaw, Poland.

This week, Jonathan is joined by Jeffrey Ponsky, Professor of Surgery, the Cleveland Clinic, USA. They review Jeff’s career with reference to advances in flexible endoscopy and the rise of medical devices, also discussing innovative approaches to surgery, and the evolution of medical training. The pair finish by evaluating modern medicine and the high cost of drugs.  

Review of the Janssen-Sponsored Virtual Satellite Symposium titled “Targeting IL-12/23 in ulcerative colitis: from evidence to bedside”, which took place at the UEG Week Virtual 2021 congress. This review covers the highlights from the presentations, providing a vital insight into the current landscape of ulcerative colitis.

Disclaimer: Sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium

Jonathan sits down for a discussion with Dr Rola Hallam, Founder, CanDo, former Medical Director, Hand in Hand for Syria, and human rights campaigner. Together, they assess the harrowing issues of health disparity across the globe, Rola’s experiences providing aid in Syria, and what we all must do to aid the humanitarian crisis.